ADITXT INC (ADTX) Stock Price, Quote, News and Overview
NASDAQ:ADTX - Nasdaq - US0070257037 - Common Stock - Currency: USD
ADTX Quote, Performance and Key Statistics
ADITXT INC
NASDAQ:ADTX (2/4/2025, 8:25:13 PM)
Premarket: 0.096 +0 (+0.21%)0.0958
-0.01 (-12.91%)
The current stock price of ADTX is 0.0958 USD. In the past month the price decreased by -53.94%. In the past year, price decreased by -99.93%.
ADTX Latest News, Press Releases and Analysis
Unusual volume stocks in Friday's session
Discover the stocks with unexpected trading volume in today's session on the US markets.
Which stocks are most active on Thursday?
Discover the most active stocks in Thursday's session. Stay informed about the stocks that are generating the most trading volume!
What's going on in today's pre-market session
Stay updated with the stocks that are on the move in Thursday's pre-market session.
Discover the most active stocks in Wednesday's session. Stay informed about the stocks that are generating the most trading volume!
Curious about the most active stocks on Wednesday? Find out which stocks are dominating the market action!
ADTX Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 18.77 | 335.67B | ||
| AMGN | AMGEN INC | 14.58 | 155.36B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 945.65 | 124.20B | ||
| GILD | GILEAD SCIENCES INC | 22.12 | 122.12B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.27 | 76.60B | ||
| ARGX | ARGENX SE - ADR | N/A | 38.95B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 34.95B | ||
| BNTX | BIONTECH SE-ADR | N/A | 28.08B | ||
| ONC | BEIGENE LTD-ADR | N/A | 23.76B | ||
| NTRA | NATERA INC | N/A | 23.00B | ||
| BIIB | BIOGEN INC | 8.73 | 20.76B | ||
| UTHR | UNITED THERAPEUTICS CORP | 15.52 | 15.78B |
Related stock screener links
About ADTX
Company Profile
Aditxt Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Richmond, Virginia and currently employs 47 full-time employees. The company went IPO on 2020-06-19. Aditxt, Inc. is a biotech company focused on discovering, developing, and deploying health innovations. The company develops and commercializes technologies with a focus on monitoring and modulating the immune system. Its portfolio includes Adimune, Inc., developing a new class of therapeutics designed to retrain the immune system to address organ rejection, autoimmunity, and allergies; Adivir, Inc., focused on identifying, developing, and commercializing new ways to treat infectious diseases, and Pearsanta, Inc., offering personalized lab testing, backed by CLIA-certified and CAP-accredited monitoring center. Adimune, Inc's immune modulation product candidate, ADI-100, is based on the Apoptotic DNA Immunotherapy platform technology, utilizes a novel approach that mimics the way bodies naturally induce tolerance to own tissues. The company also offers electroencephalography (EEG) brain monitoring technologies and devices, including NeuroCap and NeuroEEG for telehealth and tele-neurology applications.
Company Info
ADITXT INC
737 N. Fifth Street, Suite 200
Richmond VIRGINIA 94043 US
CEO: Amro Albanna
Employees: 47
Company Website: https://aditxt.com/
Investor Relations: https://www.aditxt.com/investor-relations/
Phone: 19094880844
ADTX FAQ
What is the stock price of ADTX?
The current stock price of ADTX is 0.0958 USD.
What is the symbol for ADITXT INC stock?
The exchange symbol of ADITXT INC is ADTX and it is listed on the Nasdaq exchange.
On which exchange is ADTX stock listed?
ADTX stock is listed on the Nasdaq exchange.
Is ADTX a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for ADTX, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of ADTX.
Does ADTX stock pay dividends?
ADTX does not pay a dividend.
What is the Price/Earnings (PE) ratio of ADTX?
ADTX does not have a PE ratio as the earnings reported over the last twelve months were negative (-6960.8).
What is the Short Interest ratio of ADTX stock?
The outstanding short interest for ADTX is 10.39% of its float.
ADTX Technical Analysis
ADTX Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to ADTX. ADTX may be in some trouble as it scores bad on both profitability and health.
ADTX Financial Highlights
Over the last trailing twelve months ADTX reported a non-GAAP Earnings per Share(EPS) of -6960.8. The EPS decreased by 81.22% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -154.99% | ||
| ROE | -981.55% | ||
| Debt/Equity | 1.88 |
ADTX Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 80% to ADTX. The Buy consensus is the average rating of analysts ratings from 8 analysts.
For the next year, analysts expect an EPS growth of 99.83% and a revenue growth 45.65% for ADTX